Found: 5
Select item for more details and to access through your institution.
A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host.
- Published in:
- Scientific Reports, 2016, p. 23917, doi. 10.1038/srep23917
- By:
- Publication type:
- Article
Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00726
- By:
- Publication type:
- Article
Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 11, p. 1, doi. 10.1007/s00018-022-04596-5
- By:
- Publication type:
- Article
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
- Published in:
- 2017
- By:
- Publication type:
- journal article